Athira Pharma, Inc. (ATHA)
USD 0.54
(-7.41%)
USD 0.54
(-7.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 969 Thousand | 1.04 Million | 479 Thousand | 2 Million | - | - |
| Gross Profit | -969 Thousand | -1.04 Million | -479 Thousand | -2 Million | - | - |
| Operating Expenses | 125.46 Million | 88.85 Million | 55.18 Million | 18.67 Million | 4.69 Million | 5 Million |
| Selling, General and Administrative Expenses | 33.3 Million | 32.55 Million | 21.22 Million | 6.7 Million | 1.65 Million | 1.42 Million |
| Research and Development Expenses | 93.79 Million | 61.46 Million | 42.79 Million | 13.28 Million | 3.79 Million | 3.58 Million |
| Other Expenses | -1.62 Million | -5.16 Million | -8.83 Million | -1.32 Million | -754 Thousand | -164 Thousand |
| Cost and Expenses | 125.46 Million | 88.85 Million | 55.18 Million | 18.67 Million | 4.69 Million | 5 Million |
| Operating Income | -125.46 Million | -104.01 Million | -64.02 Million | -19.99 Million | -5.44 Million | -5 Million |
| Interest Expense | - | 24.31 Million | 3000.00 | 367 Thousand | 346 Thousand | 9000.00 |
| Income Tax Expense | - | -8.37 Million | -479 Thousand | -1.32 Million | -459 Thousand | -76 Thousand |
| Earnings before Tax | -117.67 Million | -95.63 Million | -54.85 Million | -19.95 Million | -5.16 Million | -5.09 Million |
| Net Income | -117.67 Million | -87.26 Million | -54.37 Million | -18.63 Million | -4.7 Million | -5.09 Million |
| Earnings Per Share Basic | -3.10 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| Earnings Per Share Diluted | -3.09 | -2.31 | -1.47 | -0.57 | -0.14 | -0.82 |
| Weighted Average Shares Outstanding | 38.02 Million | 37.73 Million | 36.92 Million | 32.48 Million | 32.61 Million | 6.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.02 Million | 37.73 Million | 36.92 Million | 32.48 Million | 32.61 Million | 6.18 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -116.7 Million | -94.59 Million | -54.37 Million | -19.01 Million | -4.81 Million | -79 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 1.65 Million | - | - |
| Cost of Revenue | 242 Thousand | 242 Thousand | 969 Thousand | 245 Thousand | 244 Thousand | 297 Thousand |
| Gross Profit | -242 Thousand | -242 Thousand | -969 Thousand | 1.41 Million | -244 Thousand | -297 Thousand |
| Operating Expenses | 27.78 Million | 27.44 Million | 126.12 Million | 30.39 Million | 35.04 Million | 31.64 Million |
| Selling, General and Administrative Expenses | 5.87 Million | 6.45 Million | - | 6.96 Million | 7.84 Million | 10.02 Million |
| Research and Development Expenses | 21.91 Million | 20.99 Million | - | 23.43 Million | 27.2 Million | 21.61 Million |
| Other Expenses | 1.16 Million | 1.35 Million | - | 1.72 Million | 2.07 Million | 2.04 Million |
| Cost and Expenses | 28.02 Million | 27.68 Million | 127.09 Million | 30.64 Million | 35.04 Million | 31.64 Million |
| Operating Income | -28.02 Million | -27.68 Million | -127.09 Million | -30.64 Million | -35.04 Million | -31.64 Million |
| Interest Expense | - | - | - | 1.95 Million | - | - |
| Income Tax Expense | - | 198.72 Thousand | - | 2.19 Million | -244 Thousand | 121.91 Thousand |
| Earnings before Tax | -26.85 Million | -26.33 Million | -117.67 Million | -27.28 Million | -32.97 Million | -29.59 Million |
| Net Income | -26.85 Million | -26.33 Million | -117.67 Million | -27.28 Million | -32.97 Million | -29.59 Million |
| Earnings Per Share Basic | -0.70 | -0.69 | - | -0.72 | -0.87 | -0.78 |
| Earnings Per Share Diluted | -0.70 | -0.69 | - | -0.72 | -0.87 | -0.78 |
| Weighted Average Shares Outstanding | 38.37 Million | 38.32 Million | 38.02 Million | 38.11 Million | 38.05 Million | 37.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.37 Million | 38.32 Million | 38.02 Million | 38.11 Million | 38.05 Million | 37.99 Million |
| Gross Margin | - | - | - | 0.85 | - | - |
| EBIT Margin | - | - | - | -18.36 | - | - |
| Profit Margin | - | - | - | -16.48 | - | - |
| EBITDA | -27.78 Million | -27.44 Million | - | -30.39 Million | -35.04 Million | -31.39 Million |
| Earnings Before Tax Margin | - | - | - | -18.50 | - | - |
TTB
1161
JR
NUSA
4863
BCKIY